1.Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes--
systematic overview of prospective observational studies. Diabetologia. 2005; 48:2460–9.
2. Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and
care. Lancet. 2017; 390: 2673-2734.
3. Mukadam N, Sommerland A, Huntley J, et al. Population attributable fractions for risk
factorsfordementiainlow-incomeandmiddle-incomecountries:ananalysisusing
cross-sectional survey data. Lancet Glob Health. 2019; 7:e596-603.
4. OttA,StolkRP, van HarskampF, Pols HA, etal.Diabetesmellitusandtheriskofdementia:
The Rotterdam Study. Neurology. 1999; 53(9): 1937-1942.
5. Velayudhan L. Risk of developing dementia in people with diabetes and mild
cognitive impairment. Br J Psychiatry. 2010;196:36-40.
6.Mejía-ArangoS,Zúñiga-GilC.Diabetesmellituscomofactorderiesgodedemencia
en la población adulta mayor mexicana. Rev Neurol. 2011; 53:397-405.
7. Huang C, Chung C, Leu H, et al. Diabetes Mellitus and the Risk of Alzheimer’s
Disease: A Nationwide Population-Based Study. PLoS ONE. 2014; 9:e87095.
8.McNayEC,CoteroVE. Mini-review: impact of recurrent hypoglycemia on cognitive
and brain function. Physiol Behav. 2010; 100: 234-238.
9. American Diabetes Association: 6. Glycemic targets: Standards of Medical Care in
Diabetes 2019. [Diabetes Care 42(Suppl. 1):S61–S70 website]. 2019. Available at:
https://hyp.is/hQ0b7rO6Eemy96878HFnAg/care.diabetesjournals.org/content/42/Supp
lement_1/S61. Accessed 13 October 2019
10. Munshi M. Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician
Needs to Know. Diabetes Care. 2017; 40:461-467.
11. Kirkman M, Jones-Briscoe N, Clark N, et al. Diabetes in Older adults. J Am Geriatr
Soc. 2012; 60: 2342–2356.
12. Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on
brain structure and function in people with type 2 diabetes (ACCORD MIND): a
randomised open-label substudy. Lancet Neurol. 2011; 10: 969-977.
13. Wong R, Michaels-Obregon A, Palloni A. Cohort Health and Aging Study (MHAS).
Int J Epidemiol. 2017; 46: e2.
14. Kumar A, Wong R, Ottenbacher KJ, et al. Prediabetes, undiagnosed diabetes, and
diabetes among Mexican adults: findings from the Mexican Health and Aging
Study. Ann Epidemiol. 2016; 26:163-70.
15. MHAS: TheMexicanHealthandAgingStudy[MHAS2012DataFilesDescription,
Version 2 website]. Available at: http://www.mhasweb.org. Accessed 10 September
2019
16. Strauss SM, Rosedale M, Pesce MA, et al. Point-of-Care HbA1c Testing with the
A1cNowTestKitinGeneralPracticeDentalClinics:APilotStudyInvolvingIts
Accuracy and Practical Issues in Its Use. Point Care. 2014;13:142-147.
17. Glosser G, Wolfe N, Albert M, et al. Cross-Cultural Cognitive Examination:
Validation of a Dementia Screening Instrument for Neuroepidemiological Research. J
Am Geriatr Soc. 1993; 41: 931-939.
18. Mejia-Arango S, Wong R, Michaels-Obregón A. Normative and standardized data for
cognitive measures in the Mexican health and Aging Study. Salud Publica Mex. 2015;
57: 90-6.
19.Bahat G, Tufan F, Saka B, et al. Which body mass index (BMI) is better in the elderly
for functional status? Arch Gerontol Geriatr. 2012; 54:78-81.
20. Aguilar-Navarro S, Fuentes-Cantú A, Ávila-Funes J, et al. Validez y confiabilidad del
cuestionariodelENASEMparaladepresiónenadultosmayores. Salud Publica Mex.
2007; 49: 256-262.
21. Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia
risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol.
2013; 1: 183–190.
22.RawlingsAM,SharrettAR,AlbertMS,etal.TheAssociationofLate-LifeDiabetes
Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia:
The ARIC Study. Diabetes Care. 2019; 42:1248–1254.
23.KoekkoekPS,RuisC,VanDenDonkM,etal. Intensive multifactorial treatment and
cognitive functioning in screen-detected type 2 diabetes - the ADDITION-Netherlands
study: a cluster-randomized trial. Neurol Sci. 2012; 314: 71–77.
24. De Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of
cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the action
in diabetes and vascular disease: preterax and diamicron modified release controlled
evaluation (ADVANCE) trial. Diabetologia. 2009; 52: 2328–2336.
25. Morley JE. Diabetes: The diabetic brain. Nature Reviews Endocrinology. 2017; 13:
570–571.
26. Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes
mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord.
2010; 11:61-74.
27. Murman DL. The Impact of Age on Cognition. Semin Hear. 2015;36:111-21.
28. Wheeler MJ, Dempsey PC, Grace MS, et al. Sedentary behavior as a risk factor for
cognitive decline? A focus on the influence of glycemic control in brain
health. Alzheimers Dement (N Y). 2017; 3: 291-300.
29. Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain
structure. Ann N Y Acad Sci. 2015; 1353:60-71.
30. Schimming C, Luo X, Zhang C, et al. Cognitive performance of older adults in a
specialized diabetes clinic. J Diabetes. 2017; 9: 929-935.
31. Lalithambika CV, Arun CS, Saraswathy LA, et al. Cognitive impairment and its
association with glycemic control in type 2 diabetes mellitus patients. IndianJEndocr
Metab. 2019; 23:353-356.
32.ZhengF,YanL,YangZ,etal. HbA1c, diabetes and cognitive decline: the English
Longitudinal Study of Ageing. Diabetologia. 2018; 61:839-848.
33. Mordarska K, Godziejewska-Zawada M. Diabetes in the elderly. Prz Menopauzalny.
2017; 16:38-43.
34. Liu M, Wang J, He Y, et al. Awareness, treatment and control of type 2 diabetes
among Chinese elderly and its changing trend for past decade. BMC Public Health.
2016; 16: 278.
35.Custodio N, Wheelock A, Thumala D, et al. Dementia in Latin America:
EpidemiologicalEvidenceandImplicationsforPublicPolicy.FrontiersinAging
Neuroscience. 2017; 9:221.
36.ChengST.CognitiveReserveandthePreventionofDementia:theRoleofPhysical
and Cognitive Activities. Current psychiatry reports. 2016; 18: 85.
37. Khattab M, Khader YS, Al-Khawaldeh A, et al. Factors associated with poor glycemic
control among patients with Type 2 diabetes. Journal of Diabetes and Its
Complications. 2010; 24: 84-90